Jovia L. Nierenberg

机构：University of California, San Francisco, Bridge Pharma (United States) · ORCID：0000-0003-2376-6714

发表论文 49 篇 · 总被引 712 次 · h-index 15

代表论文

• High-throughput PRIME-editing screens identify functional DNA variants in the human genome (2023 · Molecular Cell · 被引 67)
• Diabetes mellitus and risk of breast cancer: a large-scale, prospective, population-based study (2023 · British Journal of Cancer · 被引 31)
• Insights From a Large-Scale Whole-Genome Sequencing Study of Systolic Blood Pressure, Diastolic Blood Pressure, and Hypertension (2022 · Hypertension · 被引 30)
• Assessment of genetic susceptibility to multiple primary cancers through whole-exome sequencing in two large multi-ancestry studies (2022 · BMC Medicine · 被引 18)
• High throughput PRIME editing screens identify functional DNA variants in the human genome (2023 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 17)
• Development and testing of a polygenic risk score for breast cancer aggressiveness (2023 · npj Precision Oncology · 被引 11)